Your browser doesn't support javascript.
loading
Preconditioning of the tumor microenvironment with oncolytic reovirus converts CD3-bispecific antibody treatment into effective immunotherapy.
Groeneveldt, Christianne; Kinderman, Priscilla; van den Wollenberg, Diana J M; van den Oever, Ruben L; Middelburg, Jim; Mustafa, Dana A M; Hoeben, Rob C; van der Burg, Sjoerd H; van Hall, Thorbald; van Montfoort, Nadine.
Afiliación
  • Groeneveldt C; Department of Medical Oncology, Oncode Institute, Leiden University Medical Center, Leiden, The Netherlands.
  • Kinderman P; Department of Medical Oncology, Oncode Institute, Leiden University Medical Center, Leiden, The Netherlands.
  • van den Wollenberg DJM; Department of Cell and Chemical Biology, Leiden University Medical Center, Leiden, The Netherlands.
  • van den Oever RL; Department of Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands.
  • Middelburg J; Department of Medical Oncology, Oncode Institute, Leiden University Medical Center, Leiden, The Netherlands.
  • Mustafa DAM; Department of Pathology, Tumor Immuno-Pathology Laboratory, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.
  • Hoeben RC; Department of Cell and Chemical Biology, Leiden University Medical Center, Leiden, The Netherlands.
  • van der Burg SH; Department of Medical Oncology, Oncode Institute, Leiden University Medical Center, Leiden, The Netherlands.
  • van Hall T; Department of Medical Oncology, Oncode Institute, Leiden University Medical Center, Leiden, The Netherlands nvanmontfoort@lumc.nl t.van_hall@lumc.nl.
  • van Montfoort N; Department of Medical Oncology, Oncode Institute, Leiden University Medical Center, Leiden, The Netherlands nvanmontfoort@lumc.nl t.van_hall@lumc.nl.
J Immunother Cancer ; 8(2)2020 10.
Article en En | MEDLINE | ID: mdl-33082167
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Anticuerpos Biespecíficos / Viroterapia Oncolítica / Inmunoterapia Tipo de estudio: Prognostic_studies Límite: Animals / Female / Humans / Male Idioma: En Revista: J Immunother Cancer Año: 2020 Tipo del documento: Article País de afiliación: Países Bajos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Anticuerpos Biespecíficos / Viroterapia Oncolítica / Inmunoterapia Tipo de estudio: Prognostic_studies Límite: Animals / Female / Humans / Male Idioma: En Revista: J Immunother Cancer Año: 2020 Tipo del documento: Article País de afiliación: Países Bajos